Announcements Trials
Browse Landscape

Status

Unknown 7Recruiting 7Terminated 3Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Invasive Aspergillosis 1Head and Neck Neoplasms 1Colonic Neoplasms 1Chronic Disease 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Registries × Clear all
NCT03221075 2023-05-12

CLARITY

University Hospital of Cologne

Completed
203 enrolled

Invasive Aspergillosis

NCT03546322 2022-07-01

Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers

University of California, San Francisco

Completed
802 enrolled
Head & Neck

Chronic Disease, Head and Neck Neoplasms

NCT01310972 2018-08-10

Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

King Faisal Specialist Hospital & Research Center

Completed
6 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡